Cantor Fitzgerald reiterated an overweight rating on BioPharma shares, reducing the target price and setting a buy rating.
5 reports, 2 independent
Updated Oct 11
Gone quiet
- Reports
- 5
- Developments
- 2
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald reiterated an overweight rating on BioPharma shares, reducing the target price and setting a buy rating.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Jefferies set a $18.00 target price on BioPharma shares.1 source
Cantor Fitzgerald reiterated an overweight rating on BioPharma shares, reducing the target price and setting a buy rating.1 source
Keep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
- The event reports that Brooke Rollins serves as Trump's Agriculture Secretary and notes that Lutnick previously ran Cantor Fitzgerald.
- Agilysys CEO Ramesh Srinivasan sold significant company shares, with the transaction disclosed via filings with the SEC, concurrent with a rating from Cantor Fitzgerald.
-
BioPharma
company in Jílové u Prahy, Czech Republic
Related events
- Cantor Fitzgerald and Jefferies Financial Group downgraded EyePoint Pharmaceuticals' stock rating from overweight/buy to neutral/hold on October 19, 2026.
- Cantor Fitzgerald raised its price target and gave an overweight rating for SOL Strategies Inc. on October 11, 2026.
- Avalo Therapeutics received multiple rating changes and analyst coverage from firms including Cantor Fitzgerald, Bank of America, and Weiss Ratings.
- Cantor Fitzgerald and Jefferies Financial Group raised price targets and gave 'buy' ratings on UnitedHealth Group stock.
- Multiple financial firms, including Cantor Fitzgerald and William Blair, issued rating updates and price targets for various stocks on August 10, 2026.